Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - Protea Biosciences Group, Inc.v400114_ex31-2.htm
EX-21.1 - EXHIBIT 21.1 - Protea Biosciences Group, Inc.v400114_ex21-1.htm
EX-10.7 - EXHIBIT 10.7 - Protea Biosciences Group, Inc.v400114_ex10-7.htm
EX-10.6 - EXHIBIT 10.6 - Protea Biosciences Group, Inc.v400114_ex10-6.htm
EX-31.1 - EXHIBIT 31.1 - Protea Biosciences Group, Inc.v400114_ex31-1.htm
EX-10.88 - EXHIBIT 10.88 - Protea Biosciences Group, Inc.v400114_ex10-88.htm
EXCEL - IDEA: XBRL DOCUMENT - Protea Biosciences Group, Inc.Financial_Report.xls
10-K - FORM 10-K - Protea Biosciences Group, Inc.v400114_10k.htm

  

Exhibit 32.1

 

CERTIFICATION

 

In connection with the Annual Report of Protea Biosciences Group, Inc. (the “Company”) on Form 10-K for the year ending December 31, 2014 as filed with the Securities and Exchange Commission (the “Report”), we, Stephen Turner, Chief Executive Officer (Principal Executive Officer) and Edward Hughes, Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of our knowledge:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

 

   Date: February 13, 2015  
     
  /s/ Stephen Turner  
  Stephen Turner  
  Chief Executive Officer (Principal Executive Officer)  
     
  /s/ Edward Hughes  
  Edward Hughes  
  Chief Financial Officer (Principal Financial and Accounting Officer)